Gene targeting in human pluripotent stem cells with adeno-associated virus vectors

被引:38
|
作者
Mitsui, Kaoru [1 ]
Suzuki, Keiichiro [1 ]
Aizawa, Emi [1 ]
Kawase, Eihachiro [2 ]
Suemori, Hirofumi [3 ]
Nakatsuji, Norio [2 ,4 ]
Mitani, Kohnosuke [1 ]
机构
[1] Saitama Med Univ, Gene Therapy Div, Res Ctr Genom Med, Saitama 3501241, Japan
[2] Kyoto Univ, Inst Frontier Med Sci, Dept Dev & Differentiat, Sakyo Ku, Kyoto 6068507, Japan
[3] Kyoto Univ, Inst Frontier Med Sci, Lab Embryon Stem Cell Res, Stem Cell Res Ctr,Sakyo Ku, Kyoto 6068507, Japan
[4] Kyoto Univ, Inst Integrated Cell Mat Sci, Sakyo Ku, Kyoto 6068507, Japan
关键词
Human embryonic stem cells; Human induced pluripotent stem cells; Adeno-associated virus vectors; Homologous recombination; Hypoxanthine phosphoribosyl transferase 1; NANOG; EXPRESSION; LOCUS; MOUSE; LINES; IDENTIFICATION; INDIVIDUALS; INTEGRATION; SEROTYPES;
D O I
10.1016/j.bbrc.2009.08.075
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Human pluripotent stem cells, such as embryonic stem cells (hESCs) and induced pluripotent stem cells (hiPSCs), have the ability to differentiate into various cell types, and will become a potential source of cellular materials for regenerative medicine. To make full use of hESCs or hiPSCs for both basic and clinical research, genetic modi. cation, especially gene targeting via homologous recombination (HR), would be an essential technique. This report describes the successful gene targeting of the hypoxanthine phosphoribosyl transferase 1 (HPRT1) and the NANOG loci in human pluripotent stem cells with adeno-associated virus (AAV) vectors. At the HPRT1 locus, up to 1% of stable transformants were targeted via HR with an AAV-HPRT1 targeting vector, without loss of pluripotency. On the other hand, 20-87% of stable transformants were targeted using an AAV-NANOG-targeting vector designed for the promoter-trap strategy. In the KhES-3 cell line, which shows particularly high fragility to experimental manipulation, gene targeting was successful only by using an AAV vector but not by electroporation. In addition to hESC, gene targeting was achieved in hiPSC lines at similar frequencies. These data indicate that AAV vectors may therefore be a useful tool to introduce genetic modi. cations in hESCs and hiPSCs. (C) 2009 Elsevier Inc. All rights reserved.
引用
收藏
页码:711 / 717
页数:7
相关论文
共 50 条
  • [21] Adeno-associated virus vectors vascular gene delivery
    Lynch, CM
    Hara, PS
    Leonard, JC
    Williams, JK
    Dean, RH
    Geary, RL
    CIRCULATION RESEARCH, 1997, 80 (04) : 497 - 505
  • [22] Adeno-associated virus (AAV) vectors in gene therapy
    Serra, C
    Zentilin, L
    Tafuro, S
    Falaschi, A
    Giacca, M
    MINERVA BIOTECNOLOGICA, 1997, 9 (03) : 155 - 165
  • [23] Gene Therapy Using Adeno-Associated Virus Vectors
    Daya, Shyam
    Berns, Kenneth I.
    CLINICAL MICROBIOLOGY REVIEWS, 2008, 21 (04) : 583 - 593
  • [24] Adeno-associated virus vectors for therapeutic gene transfer
    Stilwell, JL
    Samulski, RJ
    BIOTECHNIQUES, 2003, 34 (01) : 148 - +
  • [25] Directed evolution of adeno-associated virus for enhanced gene delivery to pluripotent and adult neural stem cells
    Bartel, Melissa A.
    Schaffer, David V.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2013, 245
  • [26] Adeno-Associated Virus Vectors and Neurological Gene Therapy
    Ojala, David S.
    Amara, Dominic P.
    Schaffer, David V.
    NEUROSCIENTIST, 2015, 21 (01): : 84 - 98
  • [27] Gene therapy: Recombinant adeno-associated virus vectors
    Smith-Arica J.R.
    Bartlett J.S.
    Current Cardiology Reports, 2001, 3 (1) : 43 - 49
  • [28] Gene therapy using adeno-associated virus vectors
    Muramatsu, Shin-ichi
    CANCER SCIENCE, 2018, 109 : 1200 - 1200
  • [29] Adeno-associated virus vectors for gene transfer to the brain
    Okada, T
    Nomoto, T
    Shimazaki, K
    Wang, LJ
    Lu, YY
    Matsushita, T
    Mizukami, H
    Urabe, M
    Hanazono, Y
    Kume, A
    Muramatsu, S
    Nakano, I
    Ozawa, K
    METHODS, 2002, 28 (02) : 237 - 247
  • [30] Engineering adeno-associated virus vectors for gene therapy
    Chengwen Li
    R. Jude Samulski
    Nature Reviews Genetics, 2020, 21 : 255 - 272